Video Presentations

The Pathogenesis of Type 2 Diabetes The Potential Impact of Longer-Duration GLP-1 Therapies on T2DM Treatment Approaches and Patient Outcomes Incretin Therapy in Type 2 Diabetes Applied: Navigating and Making Changes in an Ever Changing Environment Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: How Do They Exert Their Metabolic Actions? Inside the Doctor's Study: Addressing Cardiovascular Issues in Diabetes with Ralph DeFronzo Diabetes, Obesity and CVD: An Overview of the Related Physiology and Comprehensive Treatment Approaches Looking Beyond Glucose Control in Type 2 Diabetes: The Cardiovascular, Cardioprotective, and Weight Effects of GLP-1 Q&A Leveraging Weight Loss in the Treatment of Type 2 Diabetes Amylin and Pramlintide: Physiology and Its Role in the Treatment of Type 1 Diabetes, Type 2 Diabetes, and Obesity Clinical Approaches to Mimicking Normal Pancreatic Physiology Using Insulin and Amylin Replacement Therapy Biology of the Incretin Hormones Overcoming Injection Anxiety in Your Diabetes Patient Hypogonadism, Erectile Dysfunction and Diabetes: Heartfelt Problems The Metabolic Syndrome and Prediabetes: Can We Prevent Diabetes? Clinical Decision Making Around Incretin-Based Therapies: Re-examining the Safety Data -- Part 2 Clinical Decision Making Around Incretin-Based Therapies: Re-examining the Safety Data -- Part 1 Addressing Type 2 Diabetes at Its Core: Disease-Modifying Therapies Applied